subscribeSubscribe
Enforcement Report - Week of February 7, 2024

Enforcement Report - Week of February 7, 2024
FDA
07 Feb 2024
Share Share
Drug mix-up prompts Azurity to recall 1 lot of Zenzedi

Drug mix-up prompts Azurity to recall 1 lot of Zenzedi
FIERCE PHARMA
26 Jan 2024
Share Share
Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Zenzedi® (dextroamphetamine sulfate tablets, USP) 30 mg Due to a Mislabeled Package During Manufacturing

Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Zenzedi® (dextroamphetamine sulfate tablets, USP) 30 mg Due to a Mislabeled Package During Manufacturing
FDA
25 Jan 2024
Share Share
Lawmakers push FDA, DEA for update amid Adderall shortage

Lawmakers push FDA, DEA for update amid Adderall shortage
Zoey Becker FIERCE PHARMA
13 Oct 2023
Share Share
Glenmark and Cediprof announce exclusive distribution agreement in US

Glenmark and Cediprof announce exclusive distribution agreement in US
ECONOMIC TIMES
09 Mar 2023
Share Share
Granules gets USFDA`s nod for Amphetamine capsules

Granules gets USFDA`s nod for Amphetamine capsules
ECONOMIC TIMES
24 Jan 2023
Share Share
XELSTRYM transdermal system, CII, to be revealed as available soon at APSARD

XELSTRYM transdermal system, CII, to be revealed as available soon at APSARD
PR NEWSWIRE
10 Jan 2023
Share Share
FDA`s drug shortages leader wants companies to start reporting increases

FDA`s drug shortages leader wants companies to start reporting increases
Tyler Patchen ENDPTS
02 Dec 2022
Share Share
Tris Pharma Announces Continued Supply and Availability of DYANAVEL Tablets

Tris Pharma Announces Continued Supply and Availability of DYANAVEL Tablets
PRNEWSWIRE
19 Oct 2022
Share Share
Enforcement Report - Week of September 21, 2022

Enforcement Report - Week of September 21, 2022
FDA
21 Sep 2022
Share Share